Sign Out
Each tablet contains phenylpropanolamine HCl 15 mg and brompheniramine maleate 12 mg.
Each 5 mL (1 tsp) syrup contains phenylpropanolamine HCl 12.5 mg and brompheniramine maleate 4 mg.
Each mL of syrup for oral drops contains phenylpropanolamine HCl 6.25 mg and brompheniramine maleate 2 mg.
Nasatapp is a combination of the decongestant, phenylpropanolamine HCl, and the antihistamine, brompheniramine maleate. This combination reduces excessive nasopharyngeal secretion and diminishes inflammatory mucosal edema and congestion in the upper respiratory tract. The antihistamine action of brompheniramine maleate reduces or diminishes the allergic response of nasal tissues. It is complemented by the mild vasoconstrictor action of phenylpropanolamine HCl, which provides a nasal decongestant effect.
